Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adlai Nortye, Arcturus, Ascletis, Beigene, Biogen, Biontech, Biothera Solutions, Daewoong, Eisai, Eli Lilly, Galecto, Harbour Biomed, Innovent Biologics, Kintor, Moderna, NLC, Obi, Oncolytic, Pfizer, Remegen, SAB, Telix, TFF, Todos Medical, Valneva.